TMDX
TransMedics Group Inc
NASDAQ: TMDX · HEALTHCARE · MEDICAL DEVICES
$98.57
-2.66% today
Updated 2026-04-29
Market cap
$3.41B
P/E ratio
20.24
P/S ratio
5.62x
EPS (TTM)
$4.87
Dividend yield
—
52W range
$89 – $156
Volume
1.0M
TransMedics Group Inc (TMDX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-16.27M | $-24.11M | $-23.10M | $-25.98M | $-32.29M | $-30.27M | $-28.86M | $-45.82M | $-13.03M | $48.80M | $192.84M |
| Capital expenditures | $1.00M | $1.48M | $263000.00 | $418000.00 | $165000.00 | $455000.00 | $3.52M | $11.91M | $179.06M | $129.74M | $59.25M |
| Depreciation | $381000.00 | $426000.00 | $630000.00 | $769000.00 | $1.22M | $1.58M | $1.82M | $3.48M | $8.18M | $19.76M | — |
| Stock-based comp | — | $45000.00 | $70000.00 | $144000.00 | $854000.00 | $2.41M | $6.88M | $10.32M | $19.79M | $33.22M | $36.86M |
| Free cash flow | $-17.27M | $-25.59M | $-23.36M | $-26.40M | $-32.45M | $-30.72M | $-32.38M | $-57.72M | $-192.09M | $-80.94M | $133.59M |
| Investing cash flow | $-3.80M | $-39.67M | $24.86M | $12.31M | $-60.50M | $-41.60M | $29.27M | $54.51M | $-193.95M | $-129.30M | — |
| Financing cash flow | $29.00M | $63.54M | $3000.00 | $22.06M | $92.72M | $75.55M | $1.39M | $167.93M | $400.42M | $22.87M | — |
| Dividends paid | — | — | — | — | — | $357000.00 | — | — | $51.12M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | $1.80M | — | — | — | — |